Work

Comparison of Eligibility Criteria and Baseline Characteristics Between the Patient Populations of evoke and evoke+, Clarity AD and TRAILBLAZER-ALZ-2 (P12-3.018)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000211264

Authors: Paul Mystkowski, Howard Feldman, Philip Scheltens, Oskar Hansson, Mary Sano, Wiesje van der Flier, Lars Bardtrum, Peter Johannsen, Rose Jeppesen, Teresa Leon, Charlotte Thim Hansen, Jeffrey Cummings

Institutions: University of California San Diego, EQT (United States), Lund University, Skåne University Hospital, James J. Peters VA Medical Center, Icahn School of Medicine at Mount Sinai, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Novo Nordisk (Denmark), University of Nevada, Reno

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409237253

FWCI:

Cites:

Cited by:

Related to: 10